TBRG1 and B-cell non-Hodgkin lymphoma: NIAM inhibition by miR-155 was associated with increased proliferation of BL cells, suggesting that the oncogenic role of miR-155 in B cell lymphomas involves targeting the tumor suppressor NIAM [36] (Figure 2).